UBS Group AG - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 1 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$1,0000.0%1,0000.0%0.00%
Q1 2020$1,0000.0%1,0000.0%0.00%
Q4 2019$1,0000.0%1,0000.0%0.00%
Q3 2019$1,0000.0%1,0000.0%0.00%
Q2 2019$1,0000.0%1,0000.0%0.00%
Q1 2019$1,0000.0%1,0000.0%0.00%
Q4 2018$1,0000.0%1,0000.0%0.00%
Q3 2018$1,0000.0%1,0000.0%0.00%
Q2 2018$1,0000.0%1,0000.0%0.00%
Q1 2018$1,000
-98.8%
1,0000.0%0.00%
Q4 2017$80,000
+7900.0%
1,0000.0%0.00%
Q3 2017$1,0000.0%1,0000.0%0.00%
Q2 2017$1,0001,0000.00%
Other shareholders

There were no reported owners of MERRIMACK PHARMACEUTICALS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders